Andreas von Deimling

Prof. Andreas von Deimling is a Full Professor and Medical Director of Neuropathology at the University of Heidelberg, leading the Clinical Cooperation Unit Neuropathology at the German Cancer Research Center. His academic career includes roles as a Resident in Zurich and Harvard postdoc, followed by professorships in Bonn and Charité Berlin before assuming his current position since 2007.

Research focuses on neuropathology and molecular genetics of central/peripheral nervous system tumors, with emphasis on tumor classification, molecular diagnostics, and therapeutic strategies. His work integrates DNA methylation profiling, organoid models, and AI-driven histopathology to advance CNS tumor diagnostics and treatment.

Key contributions include cIMPACT-NOW updates for CNS tumor classification, molecular profiling of meningiomas, and GBM organoid-based drug testing. Collaborations span global institutions, and his research bridges basic science with clinical practice in neuro-oncology.